Erratum. Renal Effects of DPP-4 Inhibitor Sitagliptin or GLP-1 Receptor Agonist Liraglutide in Overweight Patients With Type 2 Diabetes: A 12-Week, Randomized, Double-Blind, Placebo-Controlled Trial. Diabetes Care 2016;39:2042–2050

Detalles Bibliográficos
Autores principales: Tonneijck, Lennart, Smits, Mark M., Muskiet, Marcel H.A., Hoekstra, Trynke, Kramer, Mark H.H., Danser, A.H. Jan, ter Wee, Piet M., Diamant, Michaela, Joles, Jaap A., van Raalte, Daniel H.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Diabetes Association 2019
Materias:
Errata
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6385692/
https://www.ncbi.nlm.nih.gov/pubmed/30674545
http://dx.doi.org/10.2337/dc19-er03

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6385692/
https://www.ncbi.nlm.nih.gov/pubmed/30674545
http://dx.doi.org/10.2337/dc19-er03

Ejemplares similares